Barchart.com
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Nabriva Therapeutics Plc (NBRV)

Nabriva Therapeutics Plc (NBRV)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.4200 unch (unch) 07/31/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.4200 unch (unch) -
News & Headlines for Mon, Jul 31st, 2023
Help
Go To:
Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis Globe Newswire - Thu Aug 11, 2022

- Topline Data Expected First Quarter 2023 -...

NBRV : 1.4200 (unch)
Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update Globe Newswire - Wed Aug 3, 2022

-Net Product Sales of $8.7M Grew 25% versus Q2 2021- -SIVEXTRO Prescription Demand Grew 28% versus Q2 2021- -Conference Call Today at 4:30 p.m. Eastern...

NBRV : 1.4200 (unch)
Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022 Globe Newswire - Wed Jul 20, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., July 20, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

NBRV : 1.4200 (unch)
Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals Globe Newswire - Mon Jul 18, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., July 18, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

NBRV : 1.4200 (unch)
Nabriva Therapeutics to Present at the H.C. Wainwright Global Investment Conference Globe Newswire - Fri May 13, 2022

DUBLIN, Ireland, May 13, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization...

NBRV : 1.4200 (unch)
Nabriva Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update Globe Newswire - Thu May 5, 2022

-SIVEXTRO Distribution and Promotion Agreement with Merck Formally Extended Through at Least 2026- -SIVEXTRO Prescription Demand Grew 10% Versus Q1...

NBRV : 1.4200 (unch)
Nabriva Extends Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S. Through the End of 2026 Globe Newswire - Thu May 5, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) --  Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

NBRV : 1.4200 (unch)
Nabriva Therapeutics to Report First Quarter 2022 Financial Results and Recent Corporate Highlights on May 5, 2022 Globe Newswire - Mon May 2, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

NBRV : 1.4200 (unch)
Nabriva Therapeutics Announces First Patient Enrolled in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis Globe Newswire - Mon Apr 11, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., April 11, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

NBRV : 1.4200 (unch)
Nabriva Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update Globe Newswire - Tue Mar 29, 2022

-Total revenue of $9.3 million driven by continued SIVEXTRO prescription growth- -Net product sales increased 8% sequentially in Q4 2021 versus Q3 2021- ...

NBRV : 1.4200 (unch)

Barchart Exclusives

Can Grain and Oilseed Prices Higher? Barchart - 15 minutes ago
While corn, soybean, and wheat prices are higher than their most recent lows, they remain significantly lower than the 2022 high. As the agricultural commodities that feed and increasingly fuel the world are at the beginning of the 2025 crop year, the weather and other issues will determine the path of least resistance of prices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot